TL;DR — Three non-redundant legs: NMN (NAD+ fuel), Ca-AKG (TCA + epigenetic support), resveratrol PM (SIRT1 → PGC-1α biogenesis). Highest mitochondrial hallmark coverage in the TNiC OTC catalog. Run 24 weeks; track NAD+A molecule every cell needs for energy production, DNA repair, and activating longevity genes (sirtuins). Full glossary → at week 4 and resting HR weekly.
Why this stack exists
Mitochondrial aging is not one failure — it is energy depletion, poor recycling, and weak biogenesis happening together. Single-compound protocols often fix one leg while leaving the wheel wobbling.
| Layer | Compound | Role | Analogy |
|---|---|---|---|
| Fuel | NMN | Restores NAD+ for SIRT3 mitophagyA specific form of autophagy that selectively removes damaged or dysfunctional mitochondria, replacing them with healthy ones. Full glossary → + PARP | Battery |
| Flux | Ca-AKG | TCA cycle anaplerosis + TET cofactor | Engine timing |
| Signal | Resveratrol | SIRT1 → PGC-1α biogenesis | Ignition |
← Swipe for more columns →
Gap analysis — what breaks when you use only one:
- NMN alone → NAD+ rises but biogenesis signaling may stay flat without SIRT1/PGC-1α drive
- Resveratrol alone → SIRT1 activation starved without NAD+ cosubstrate
- Ca-AKG alone → metabolic support without NAD+-dependent quality control
Suggested visual
Suggested visual: Mitochondrial lifecycle wheel — biogenesis (PGC-1α) → ATP production (NAD+/TCA) → quality control (SIRT3) → mitophagy clearance. Each compound at its spoke.
Mechanistic synergyWhen two compounds together produce greater effect than either alone. Full glossary → map
`
Lifestyle load + age
↓
[NMN] → NAD+ pool → SIRT3 mitophagy + PARP repair
↓
[Ca-AKG] → TCA anaplerosis + epigenetic enzyme support
↓
[Resveratrol PM] → SIRT1 → PGC-1α → mitochondrial biogenesis
↓
Improved mito quality → ↓ ROS → ↓ inflammation cross-talk
`
Hallmarks addressed: Mitochondrial dysfunction · Epigenetic alterations · Genomic instability · Cellular senescence · Nutrient sensing — with mechanistic independence between legs.
Evidence per leg
| Compound | Tier | Key human / preclinical data |
|---|---|---|
| NMN | A | NAD+ elevation, functional signals (PMID 36482258) |
| Ca-AKG | A/B | Mouse lifespan extension (PMID 32877690); emerging human metabolic data |
| Resveratrol | B | Strong SIRT1/PGC-1α mechanism; mixed standalone human outcomes |
Combination logic: No single RCT tested this exact triad. Architecture grades Tier A for breadth of mito hallmark coverage with Tier A/B legs — same standard Examine uses for mechanistic stack reviews.
Rajman et al. Cell Metabolism 2018 — NAD+ intermediates as mitochondrial therapeutics. Stack combines NAD+ restoration with biogenesis and metabolic flux support.
Is the NAD+ Mito Stack right for you?
Mitochondrial dysfunction is a top-3 priority hallmark for you?
node | On diabetes medications or blood thinners?
redflag | Physician clearance — resveratrol and Ca-AKG affect glucose and platelets
Start NMN only week 1–2 → add Ca-AKG week 3 → resveratrol PM week 4
node | Primary issue is oxidative stress / low GSH?
Run NRF2 Defense Triad first 12 weeks → add this stack if energy plateaus
Prioritize Zone 2 + sleep 8 weeks before supplement spend
Educational decision aid — a way to organize the evidence, not a prescription. Doses and timing shown are those used in studies; confirm anything you act on with a clinician or pharmacist.
AM/PM choreography (ramp-in protocol)
| Step | Week | Time | Compound | Dose | Notes |
|---|---|---|---|---|---|
| 1 | 1–2 | AM fasted | NMN | 250 mg | Establish NAD+ response |
| 2 | 3+ | AM breakfast | Ca-AKG | 1 g → 2 g | Titrate GI tolerance |
| 3 | 4+ | PM dinner | Resveratrol | 150–250 mg → 500 mg | With dietary fat |
← Swipe for more columns →
Why ramp-in matters: GI tolerance and glucose shifts are easier to attribute when legs are staggered. Full triad on day one obscures which compound caused nausea or hypoglycemia.
Day-one setup (15 minutes)
- Week 1 pill organizer: NMN AM slot only — confirm NAD+ response before adding legs
- Log resting HR + morning energy daily in Labs hub or notes
- Baseline labs: NAD+ index minimum; add fasting glucose if metabolic risk
- Set week 4 review — add resveratrol only if NAD+ moved or energy ↑1 point
- Cross-read NMN compound guide for methyl donor notes
Biomarker targets
| Marker | Baseline | 12 wk | 24 wk | Stack success signal |
|---|---|---|---|---|
| NAD+ index | Log | 80+ | Sustained | Primary |
| Resting HR | Log | ↓2–3 bpm | ↓3–5 bpm | Wearable proxy |
| Fasting glucose | Log | Stable <100 | Stable | Safety |
| Subjective energy | Daily log | ≥7/10 | Sustained | Functional |
← Swipe for more columns →
NAD+ index
<75
Resting HR
68 bpm
Morning energy
5–6/10
Zone 2 tolerance
Low
NAD+ index
80+
Resting HR
63 bpm
Morning energy
7–8/10
Zone 2 tolerance
Improved
Red flags and contraindications
Hard stops — do not run this stack without clearance
- Active cancer treatment — NAD+ and polyphenol stacks require oncologist approval
- Pregnancy or breastfeeding — insufficient safety data across legs
- Diabetes on insulin/sulfonylureas — resveratrol and Ca-AKG may lower glucose; monitor weekly × 4 weeks
- Anticoagulants — resveratrol platelet effects; INR monitoring if on warfarin
- Rising resting HR despite improved fitness — arrhythmia workup before escalating NAD+
Soft cautions
Ca-AKG can cause loose stool at 2 g — split AM/PM doses. Resveratrol is light-sensitive; store capped. NMN quality varies by brand — if NAD+ flat at week 4 with perfect compliance, verify third-party testing.
Stack variants by budget
| Tier | Components | Monthly est. | Coverage |
|---|---|---|---|
| Starter | NMN 250 mg | $ | NAD+ fuel only |
| Core | NMN + Ca-AKG | $$ | Fuel + metabolic flux |
| Full triad | All three legs | $$$ | Complete mito architecture |
| Elite | Triad + NRF2 Triad | $$$$ | Mito + antioxidant orthogonal |
← Swipe for more columns →
When to add the NRF2 triad
Add GlyNAC + sulforaphane after week 12 if GSH remains low, hs-CRP stays elevated, or oxidative stressAn imbalance between reactive oxygen species (free radicals) produced by metabolism and the antioxidant systems that neutralize them. Full glossary → lifestyle factors persist — not on day one.
Personal results template
My NAD+ Mito Stack log
| Date | Week | NMN ✓ | Ca-AKG ✓ | Resv ✓ | NAD+ | RHR | Energy | Notes |
|---|---|---|---|---|---|---|---|---|
| YYYY-MM-DD | 0 | — | — | — | — | — | — | Baseline |
| YYYY-MM-DD | 4 | ✓ | — | — | — | — | — | Post-NMN only |
| YYYY-MM-DD | 12 | ✓ | ✓ | ✓ | — | — | — | Full triad |
| YYYY-MM-DD | 24 | ✓ | ✓ | ✓ | — | — | — | Primary endpoint |
← Swipe for more columns →
Compliance target: ≥85% daily adherence
Response criteria: - Win: NAD+ optimal + energy ↑2 + RHR ↓3 bpm - Iterate: NAD+ up, energy flat → confirm PM resveratrol timing with fat - Stop signal: Symptomatic hypoglycemia or muscle pain → pause, physician consult
References
- Fukamizu Y et al. NMN supplementation elevates NAD+ levels in healthy adults. GeroScience (2022). PMID 36482258
- Asadi Shahmirzadi A et al. Alpha-ketoglutarate extends lifespan in mice. Cell Metabolism (2020). PMID 32877690
Links open PubMed. TNiC does not sell supplements; citations support education, not medical advice.